For the purposes of this chapter, the following definitions apply: (a) âAIDSâ means acquired immune deficiency syndrome. (b) âAn HIV-positive individualâ means an individual who is infected with the AIDS virus. (c) âCommitteeâ means the AIDS Vaccine Research and Development Advisory Committee. (d) âGrant awardâ means an AIDS Vaccine Clinical Trial Grant Award for the Prevention of Maternal Transmission of HIV Infection. (e) âAIDS vaccine,â for the purposes of this chapter, means a vaccine that has been developed by a manufacturer and is being tested and administered for the purposes of determining whether immunization of HIV-infected pregnant women will protect against maternal transmission of the AIDS virus. Clinical trials must be conducted under an investigational new drug (IND) application on file with the federal Food and Drug Administration (FDA). (f) âResearch subjectâ means a person who is administered an AIDS vaccine, or a fetus of a woman administered an AIDS vaccine, or a child born to a woman administered an AIDS vaccine during pregnancy. (g) âResearcherâ means a person employed by or affiliated with a manufacturer or a research institution, who participates in the development or testing or administration of an AIDS vaccine, or who is involved in the diagnosis and treatment of a research subject.
‹ Prev All California sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.